stockrowAmylyx Pharmaceuticals, Inc. (AMLX) vs Trulieve Cannabis Corp. (TRLV)
- Amylyx Pharmaceuticals, Inc. AMLX 27.79 −5.48%
- Trulieve Cannabis Corp. TRLV 11.07 −4.57%
Amylyx Pharmaceuticals, Inc. and Trulieve Cannabis Corp. are both Drug Manufacturers Specialty & Generic companies. Amylyx Pharmaceuticals, Inc. is the larger, with a market value of $3.5B against $2.1B — 1.7× the size. Trulieve Cannabis Corp. grew revenue faster over the last twelve months: −9.09% against −77.1%. Amylyx Pharmaceuticals, Inc. has the higher net margin (0.00% vs −41.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Trulieve Cannabis Corp. leads on 10 and Amylyx Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | AMLX | TRLV | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | (42.65%) | 60.64% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (41.22%) | (2.45%) |
| Free cash flow margin | 0.00% | 22.43% | 0.00% |
| Return on equity | (74.73%) | (45.52%) | (0.80%) |
| Return on assets | (66.25%) | (17.61%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack